02192 MEDLIVE
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 21.03X | Oper Margin | 61.1% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 56.4% |
| Total Debt/Equity | 0.5% | Return on Equity | 6.6% |
| Price/Book | 2.00X | Return on Assets | 6.2% |
| (HKD 13.930) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 335.16 | 267.06 | 131.54 | 49.68 | 101.11 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +25.5 | +103.0 | +164.8 | -50.9 | +189.3 |
| Earnings Per Share (HKD) | 0.46 | 0.37 | 0.184 | 0.081 | 0.189 |
| Earnings Per Share Growth (%) | +24.3 | +100.9 | +128.4 | -57.4 | +189.4 |
| Dividend Per Share (HKD) | 0.280 | 0.254 | 0.075 | 0.021 | No dividend |
| P/E* (X) | 30.30 | 37.66 | 75.67 | 172.83 | 73.70 |
| Yield (%) | 2.01 | 1.82 | 0.54 | 0.15 | N/A |
| Dividend Share (%) | 60.91 | 68.67 | 40.58 | 25.93 | N/A |
| Book NAV (HKD) | 6.964 | 6.970 | 6.879 | 6.772 | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 312.035 | 243.443 | +28.2 | 173.506 |
| Operating Result | 166.477 | 158.148 | +5.3 | 102.66 |
| Associates | 0 | 0 | N/A | 0.003 |
| Profit Before Taxation | 166.477 | 158.148 | +5.3 | 102.663 |
| Taxation | 6.071 | 5.442 | +11.6 | 1.004 |
| Profit /( Loss) After Taxation | 160.406 | 152.706 | +5.0 | 101.659 |
| Minority Interests | 5.068 | 5.987 | -15.3 | 2.941 |
| Net Profit | 155.338 | 146.719 | +5.9 | 98.718 |
| Earnings Per Share () | 0.2322 | 0.2169 | +7.1 | 0.1484 |
| Dividend Per Share () | 0.1277 | 0.1295 | -1.4 | 0.1165 |
| Announcement Date | 2025-08-25 | 2024-08-27 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
